DekaBank Deutsche Girozentrale’s Albireo Pharma Inc ALBO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,000	Closed	-$1.99M	–	1348
2023 Q1	$1.99M	Hold	45,000	–	–	0.01%	723
2022 Q4	$955K	Hold	45,000	–	–	﹤0.01%	892
2022 Q3	$823K	Buy	45,000 +10,000	+29%	+$207K	﹤0.01%	925
2022 Q2	$654K	Buy	+35,000	New	+$923K	﹤0.01%	976
2021 Q3	–	Sell	-33,900	Closed	-$1.19M	–	1439
2021 Q2	$1.19M	Hold	33,900	–	–	﹤0.01%	871
2021 Q1	$1.13M	Hold	33,900	–	–	﹤0.01%	870
2020 Q4	$1.25M	Sell	33,900 -1,700	-5%	-$61.8K	﹤0.01%	794
2020 Q3	$1.13M	Buy	+35,600	New	+$1.04M	0.01%	728

Other funds holding ALBO

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ALBO Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Albireo Pharma Inc (ALBO) in Q2 2023, closing a stake of 45,000 shares — an estimated $1.99M sold.

DekaBank Deutsche Girozentrale first reported a position in ALBO in Q3 2020 and held it in 8 quarters. The position peaked at $1.99M in Q1 2023. 1 fund tracked by Wall St. Rank holds ALBO as of Q2 2023.

DekaBank Deutsche Girozentrale reported no remaining Albireo Pharma Inc position as of Q2 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 45,000 Albireo Pharma Inc shares in Q2 2023, an estimated $1.99M.
DekaBank Deutsche Girozentrale first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 8 quarters.
DekaBank Deutsche Girozentrale's Albireo Pharma Inc position peaked at $1.99M in Q1 2023.
1 fund tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.